Arcutis Biotherapeutics, Inc. (ARQT)
19.50
-0.53
(-2.65%)
USD |
NASDAQ |
May 19, 16:00
19.50
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Total Assets (Quarterly) : 460.00M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| ADMA Biologics, Inc. | 665.18M |
| MannKind Corp. | 744.40M |
| PTC Therapeutics, Inc. | 2.869B |
| Ultragenyx Pharmaceutical, Inc. | 1.296B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 270.36M |
| Shareholders Equity (Quarterly) | 189.65M |
| Debt to Equity Ratio | 0.6047 |
| Current Ratio | 2.684 |
| Net Debt Paydown Yield | -0.03% |